Most Read News

On Sept 08, 2025, the Indian shares ended marginally higher on Monday

Execution of the projects is scheduled to begin in December 2025 and continue through March 2026.

The venture will follow a 50:50 shareholding structure, with Morepen Medipath indirectly holding a 30% stake.

Kenox, a contract drug maker with a focus on inhaled and nasal products, will handle formulation and development, while Strides brings in manufacturing scale and market access.

The company’s current order book stands at about ₹1,335 crore, with demand coming from marquee clients across the oil & gas, power, chemicals, and process industries.

The order will be delivered in stages over the next six to ten months and deployed across ACME’s firm and dispatchable renewable energy (FDRE) projects as well as standalone BESS projects

The financing will be directed toward housing, land acquisition, and infrastructure projects.

Eicher Motors, Maruti Suzuki and M&M hits 52-week high in Nifty.

The project is slated for completion in 18–36 months and will require an investment of about ₹250 crore, to be funded through internal accruals and debt, if necessary.

IT stocks continued to see selling pressure. NIFTY BANK witnessed a modest revival as it recovered after 2 consecutive weeks of losses. NIFTY FMCG notched its 3rd consecutive week of gain.